A six-week group-based CBT-I intervention tailored for cardiovascular disease patients significantly improved sleep outcomes and reduced symptoms of anxiety, depression, and insomnia (p < 0.05).
Observational (n=47)
No
Does a six-week group-based cognitive-behavioral therapy for insomnia improve sleep outcomes and mental health in patients with cardiovascular disease and primary insomnia?
A six-week tailored cognitive-behavioral therapy for insomnia group intervention significantly improved sleep outcomes, anxiety, and depression in patients with cardiovascular disease.
valor p: p=< .05
Objective: There is little research assessing the use of cognitive-behavioral therapy for insomnia (CBT-I) among patients with cardiovascular disease (CVD), even less on the effects of CBT-I on CVD risk factors such as anxiety and depression, and to our knowledge, only limited studies of the efficacy of CBT-I protocols with cardiac disease-specific modifications. The objective of this study is to evaluate a group-based CBT-I intervention tailored to patients with CVD on sleep quality, duration, and mental health. Participants: A sample of 47 participants (25 men) diagnosed with primary insomnia were included in this study. Methods: This study used a pre–post design comparing outcomes before and after a group intervention. Clinicians in a cardiac center referred CVD patients with self-reported sleep disturbance to the intervention group. Following screening and confirmation of insomnia disorder, participants completed a six-week CBT-I group-based intervention tailored for patients with CVD. Participants completed sleep diaries and questionnaires, including the Insomnia Severity Index, Beck Depression Inventory-II, and Beck Anxiety Inventory, pre- and postintervention. Results: Participants’ sleep outcomes (sleep duration, maintenance, efficiency, latency, and quality) were significantly improved and patients reported significantly fewer symptoms of anxiety, depression, and insomnia following the CBT-I intervention (p values < .05). Conclusions: After participating in a CBT-I group intervention tailored for cardiac patients, patients reported improved sleep and significantly lower levels of anxiety and depression. Randomized trials of this intervention are warranted.
Heenan et al. (Sun,) conducted a observational in Cardiovascular disease and primary insomnia (n=47). Group-based cognitive-behavioral therapy for insomnia (CBT-I) vs. Pre-intervention baseline was evaluated on Sleep outcomes (duration, maintenance, efficiency, latency, quality) and symptoms of anxiety, depression, and insomnia (p=< .05). A six-week group-based CBT-I intervention tailored for cardiovascular disease patients significantly improved sleep outcomes and reduced symptoms of anxiety, depression, and insomnia (p < 0.05).